Frauke Zipp

Obere Zahlbacher Str. 67
Gutenberg, RP 55131, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 250 publications

Immune-mediated excitotoxicity in brain disorders.

Immune-mediated excitotoxicity in brain disorders.

Journal: Nature reviews. Immunology

Published: August 03, 2026

Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.

Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 01, 2026

CSF Proteins Associated With Neuroaxonal Damage in Early Active Multiple Sclerosis.

CSF Proteins Associated With Neuroaxonal Damage in Early Active Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: March 25, 2026

Treatment approaches to patients with multiple sclerosis and coexisting psoriasis - A longitudinal multicenter observational cohort study.

Treatment approaches to patients with multiple sclerosis and coexisting psoriasis - A longitudinal multicenter observational cohort study.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: February 20, 2026

In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis.

In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis.

Journal: Science translational medicine

Published: January 21, 2026

Bruton's tyrosine kinase inhibitors rescue neuronal impairment caused by B cell-mediated lymphotoxin-α release.

Bruton's tyrosine kinase inhibitors rescue neuronal impairment caused by B cell-mediated lymphotoxin-α release.

Journal: Science translational medicine

Published: October 29, 2025

Real world observation of fatigue in multiple sclerosis comparing self-guided online cognitive behavioral therapy versus psychoeducation.

Real world observation of fatigue in multiple sclerosis comparing self-guided online cognitive behavioral therapy versus psychoeducation.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: October 22, 2025

Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis.

Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 15, 2025

Neurons differentially upregulate type 2 immune cytokines and interleukin-4 receptor subtypes during neuroinflammation.

Neurons differentially upregulate type 2 immune cytokines and interleukin-4 receptor subtypes during neuroinflammation.

Journal: Acta neuropathologica communications

Published: August 05, 2025

AMPAR inhibition lowers S1P in human blood and improves murine autoimmune neuroinflammation by blocking T cell egress from lymph nodes.

AMPAR inhibition lowers S1P in human blood and improves murine autoimmune neuroinflammation by blocking T cell egress from lymph nodes.

Journal: Science translational medicine

Published: June 11, 2025

Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.

Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.

Journal: JAMA neurology

Published: June 02, 2025

HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis.

HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis.

Journal: EBioMedicine

Published: May 30, 2025

Showing 1-12 of 250

Last Updated: 09/26/2026